# PefkouFL-6000mg: Endothelial Dilation & Microcirculatory Optimization Framework

[![License: BSL-1.0](https://shields.io)](LICENSE)
[![Regulatory Framework](https://shields.io)](docs/)
[![Purity Status](https://shields.io)](forms/)

This repository serves as the definitive administrative, pharmacokinetic, and operational compliance source for the **PefkouFL-6000mg** Institutional Review Board (IRB) Expanded Access (Compassionate Use) program. The target formulation utilizes a highly concentrated 15:1 certified organic *Pinus pinaster* (Maritime Pine) Bark Extract matrix bound with pure Gum Acacia to optimize microcirculatory flow, stabilize erythrocyte membranes, and accelerate the structural flushing of metabolic and parasitic clearance debris.

## 🔬 Formulation Architecture
Unlike raw botanical powders, PefkouFL utilizes a high-potency, low-bulk polyphenolic resin extract to fit a massive 6000mg crude herb equivalent into a singular 600mg solid dosage matrix:
*   **Active Core Mass:** 400.0 mg Standardized *Pinus pinaster* Extract (15:1 Concentration Ratio).
*   **Standardization Metric:** ≥ 75.0% w/w Pure Oligomeric Proanthocyanidins (OPCs), yielding exactly 300 mg of active tracking molecules per unit dose.
*   **Polymeric Binder:** 5.0% w/w Certified Organic Gum Acacia (Gum Arabic) serving as a wet granulation adhesive matrix to ensure fast dissolution and immediate core hydration.
*   **Environmental Protection:** Compounding and storage atmospheres are restricted to a strict maximum ceiling of **35% Relative Humidity (RH)** to prevent severe hygroscopic caking of the polyphenolic core.

---

## 🫀 Key Clinical Mechanisms & Mass Transit

### 1. Biphasic Human Pharmacokinetic Clearance
When the 300 mg active proanthocyanidin load is ingested, it exhibits a distinct two-peak plasma profile:
*   **The Monomer Peak ($T_1$):** Highly bioavailable monomeric fractions (free catechin, taxifolin) undergo rapid absorption in the upper small intestine, peaking within **0.5 to 2.0 hours**.
*   **The Metabolite Peak ($T_2$):** High-molecular-weight polymers migrate to the lower colon where gut microbiota cleave the rings into **5-(3′,4′-dihydroxyphenyl)-$\gamma$-valerolactone** ($t_{1/2} \approx 13.5\text{ hours}$), creating a sustained, 24-hour therapeutic protection loop peaking between **6.0 to 10.0 hours**.

### 2. Endothelial Vasodilation
Activates endothelial nitric oxide synthase (**eNOS**) via calcium/calmodulin upregulation, converting L-arginine into gaseous Nitric Oxide ($\text{NO}^\bullet$) to relax vascular smooth muscle via the cyclic GMP pathway.

### 3. Hydrogen Atom Transfer (HAT) Membrane Shielding
Deploys high-velocity hydrogen atom donations to break the free radical chain reactions targeting erythrocyte lipid bilayers, stopping lipid peroxidation and preventing malondialdehyde (MDA) cross-linking.

### 4. Microcirculatory Fluid Flushing
By widening capillary diameters, the protocol logs a strategic increase in fluid filtration volume ($J_v$). This generates a micro-fluid hydrostatic sweep across the interstitial barrier, accelerating lymphatic drainage and pushing cell debris and detached parasites downstream toward hepatic and renal elimination gates.

---

## 📂 Repository File Structure

├── data/\
│ └── EXPANDED_ACCESS_PATIENT_METRICS.tsv # Real-time tabular microcirculatory tracking\
├── docs/\
│ ├── COA_PINUS_PINASTER_LOT_001.md # 75% Proanthocyanidin lot certification\
│ ├── DATA_PRIVACY_AND_BORDER.md # Cross-border data anonymization laws\
│ ├── DISCLAIMER.md # Core regulatory definitions\
│ ├── DISCLAIMER_GENERAL_REFERENCE.md # Compendial academic reference models\
│ ├── DISCLAIMER_GENERAL_WELLNESS.md # DSHEA structure/function boundaries\
│ ├── EXPORT_CONTROL.md # International technical data transfer rules\
│ └── FLUSH_AND_DETOX_MATHEMATICS.md # Starling equations and HAT kinetics\
├── forms/\
│ ├── DAY_0_ELIGIBILITY_GATE.md # Inclusion/Exclusion entry checklists\
│ ├── HCPCS_INSURANCE_REIMBURSEMENT.tsv # Specialized billing and J-code registry\
│ └── IRB_COMPASSIONATE_USE_APPLICATION.md # Individual Expanded Access submission form\
└── src/\
└── pharmacokinetic_simulator.py # Script modeling the biphasic valerolactone curve

```


---

## ⚙️ Core Mathematical Equations Deployed

### 1. Human Biphasic Steady-State Accumulation
$$C_{ss}(t) = \left[ \frac{F \cdot D \cdot k_a}{V_d \cdot (k_a - k_e)} \right] \cdot \left[ \frac{e^{-k_e \cdot t}}{1 - e^{-k_e \cdot \tau}} - \frac{e^{-k_a \cdot t}}{1 - e^{-k_a \cdot \tau}} \right]$$

### 2. Hydrogen Atom Transfer (HAT) Bond Dissociation Enthalpy
$$\text{BDE} = H^\circ(\text{Ar-O}^\bullet) + H^\circ(\text{H}^\bullet) - H^\circ(\text{Ar-OH})$$

### 3. Starling Microcirculatory Fluid Hydrostatic Flux
$$J_v = L_p \cdot A \cdot \left[ (P_c - P_{if}) - \sigma(\pi_p - \pi_{if}) \right]$$

---

## 🛠️ Automated Setup & Verification
To execute the repository's pharmacokinetic simulator engine and output the graph assets tracking the $\gamma$-valerolactone systemic clearance profile, install dependencies and run:

```bash
pip install numpy matplotlib
python src/pharmacokinetic_simulator.py
```

***

### 📋 Medical & Legal Disclaimer
The documentation, ledgers, and structural models maintained in this repository describe general human circulatory, chemical, and administrative parameters for software validation and compliance testing. They do not constitute personalized medical advice, clinical diagnostics, or authorized prescription guidelines. Any active implementation of this protocol must be formally verified, signed off, and audited by a licensed Institutional Review Board (IRB) and competent regional health authorities.

```
